Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
652.00    -27.00 (-3.98%)
Bid:
651.00
Ask:
654.00
Spread: 3.00 (0.461%)
Market Cap: £1.20b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

AGM Statement

7 Aug 2025 07:00

RNS Number : 3095U
Volex PLC
07 August 2025
 

7 August 2025

 

Volex plc

("Volex", the "Company", or the "Group")

AGM Statement

 

Strong trading momentum continues into FY2026

Q1 provides confidence in achieving full year expectations

 

Volex plc (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, is pleased to report a trading update for the three months ended 30 June 2025, ahead of the Company's annual general meeting, being held at 2.00 pm today.

 

Positive start to financial year underpins full year expectations

Volex has delivered a strong start to the new financial year, with the first-quarter trading performance in line with management's expectations. The positive momentum outlined at the Group's FY2025 results has continued into FY2026, despite uncertain macroeconomic conditions, reinforcing confidence in the strategy and outlook for the full year.

 

Q1 FY2026 constant currency organic revenue increased by 10.4% year-on-year. This strong growth reflects the continued momentum in the Electric Vehicles and Complex Industrial Technology end-markets, notably among Data Centre customers, as well as good growth in Off-Highway.

 

Operational execution

We continue to collaborate closely with our global customers to support their supply chain relocation strategies, navigating the evolving tariff landscape with agility.

 

As part of the ongoing integration of Murat Ticaret and the associated profitability enhancement initiatives, we have successfully closed one of the legacy sites acquired with the acquisition. All operations have been fully transitioned to other facilities within Türkiye, with no disruption to customers. This site consolidation will improve customer service and deliver operational efficiencies.

 

Outlook

The encouraging performance in the first quarter, coupled with a pipeline of commercial opportunities, underpins the Board's confidence in Volex's ability to meet its FY2026 expectations. We remain well-positioned to make further progress towards the delivery of our five-year strategic plan and to drive continued value creation for shareholders.

 

-ENDS-

 

For further information please contact:

 

Volex plc +44 (0) 1256 442570

Nat Rothschild, Executive Chairman investor.relations@volex.com

Jon Boaden, Chief Financial Officer

Peel Hunt LLP - Nominated Adviser & Joint Broker +44 (0) 20 7418 8900

Ed Allsopp

Dom Convey

Tom Graham

 

Jefferies - Joint Broker +44 (0) 20 7029 8000

Philip NobletSam Barnett

Harry Le May

 

Sodali & Co. - Media Enquiries +44 (0) 20 7250 1446

James WhiteNicholas Johnson

 About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 25 advanced manufacturing facilities, uniting 13,000 dynamic individuals from 25 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

 

Forward looking statements

This announcement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the announcement. Forward-looking statements should be regarded with caution as, by their nature, such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMPKABKOBKDDFK
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.